Flash Sale 70% Off
Give customers details about the banner image(s) or content on the template.
Research Peptide
GLP-1 receptor agonist peptide. Classification Long-acting incretin mimetic peptide. Semaglutide belongs to the GLP-1 receptor agonist class, a group of comp...
$140.00
GLP-1 receptor agonist peptide.
Classification
Long-acting incretin mimetic peptide. Semaglutide belongs to the GLP-1 receptor agonist class, a group of compounds developed to replicate the biological activity of endogenous GLP-1 while significantly extending duration of action through molecular modification.
Target Receptors
• GLP-1 Receptor – Involved in appetite regulation, satiety signaling, gastric emptying, and metabolic control.
Structure
Semaglutide is a modified analogue of native GLP-1 containing amino acid substitutions and a fatty-acid side chain that increases albumin binding and extends activity.
Research Focus
Studied for its effects on appetite control, caloric intake reduction, weight management, and metabolic regulation.